Experience. Commitment. Results.
Esperion Therapeutics, Inc. (NASDAQ: ESPR) related to its sale to funds managed by ARCHIMED. Under the terms of the proposed transaction, Esperion shareholders are expected to receive $3.16 per share in cash and the right to participate in contingent milestone payments.
Pacific Financial Corporation (OTCQX: PFLC) related to its merger with Banner Corporation. Under the terms of the proposed transaction, Pacific Financial shareholders are expected to receive 0.2633 share of Banner common stock for each share of Pacific Financial.
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) related to its sale to Chiesi Group. Under the terms of the proposed transaction, KalVista shareholders are expected to receive $27.00 per share in cash.
BNCCORP, Inc. (OTCQX: BNCC) related to its sale to OppFi, Inc. Under the terms of the proposed transaction, BNCCORP shareholders are expected to receive (i) $19.375 in cash and (ii) a number of shares of Class A common stock of OppFi equal to an exchange ratio of 1.90 shares of Class A common stock for each BNCCORP … Read more
RE/MAX Holdings, Inc. (NYSE: RMAX) related to its sale to The Real Brokerage Inc. Under the terms of the proposed transaction, RE/MAX shareholders are expected to receive either 5.152 shares of the combined company or $13.80 in cash per share.
XOMA Royalty Corporation (NASDAQ: XOMA) related to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the proposed transaction, XOMA shareholders will receive $39.00 per share in cash.
Miluna Acquisition Corp. (NASDAQ: MMTX) related to its merger with CADV Ventures S.A.
Organon & Co. (NYSE: OGN) related to its sale to Sun Pharmaceuticals Industries Limited. Under the terms of the proposed transaction, Organon shareholders will receive $14.00 per share in cash.
Helix Energy Solutions Group, Inc. (NYSE: HLX) related to its merger with Hornbeck Offshore Services, Inc. Upon completion of the proposed transaction, Helix shareholders will own approximately 45% of the combined company on a fully diluted basis.
Citizens National Corporation (OTCID: CZNL) related to its sale to Peoples Bancorp, Inc. Under the terms of the proposed transaction, Citizens National shareholders are expected to receive 2.10 common shares of Peoples and cash in the amount of $8.00 per share.